Contrast Media/Contrast Agent Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Description
The global contrast media/contrast agent market was valued at USD 5.27 Billion in 2024, driven by a surge in demand for advanced diagnostic methods across the globe. The market is expected to grow at a CAGR of 4.10% during the forecast period of 2025-2034, with the values likely to reach USD 7.88 Billion by 2034.
Contrast Media/Contrast Agent Market Overview
Contrast media, also known as contrast agents, are substances used in medical imaging to enhance the visibility of internal body structures and fluids during diagnostic procedures. These agents improve image contrast in various modalities such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Radiopaque contrast media, which include iodine-based and barium-sulfate compounds, are commonly used in X-ray and CT imaging to highlight blood vessels and gastrointestinal tracts. Paramagnetic agents, containing gadolinium, are used in MRI to enhance tissue differentiation. Microbubble contrast agents, used in ultrasound, improve the visualization of blood flow and organ structures. These agents are essential in modern diagnostic medicine, providing clearer and more detailed images for accurate diagnosis and treatment planning.
The shift towards minimally invasive diagnostic and therapeutic procedures has increased the utilization of contrast agents to enhance imaging accuracy and outcomes. Also, the growth in the number of diagnostic imaging centers, particularly in emerging economies, expands the accessibility and availability of imaging services, driving the demand for contrast agents.
Contrast Media/Contrast Agent Market Growth Drivers
Advancements in Imaging Technologies Augmenting the Market Growth
Advancements in imaging technologies improve the accuracy and quality of diagnostic procedures, driving the demand for contrast media. Enhanced imaging systems require high-quality contrast agents to optimize their performance. For instance, Siemens Healthineers introduced Naeotom Alpha, the world’s first photon-counting CT scanner with a technology that provides high-resolution images at lower radiation doses compared to traditional CT scanners. Photon-counting detectors capture more detailed information about tissues, improving contrast resolution and making the use of contrast media more effective. This advancement supports the growing need for precise imaging in complex medical conditions.
Frequent Product Approvals and Launches to Meet Rising Contrast Media/Contrast Agent Market Demand
The introduction of new and innovative contrast agents is expanding the options available to clinicians, enhancing the quality of diagnostic imaging and driving market growth. For example, in August 2022, Guerbet and Bracco Imaging received FDA approval for Gadopiclenol, a new macrocyclic gadolinium-based contrast agent (GBCA) for MRI. Gadopiclenol features high relaxivity, allowing for lower doses while still providing excellent image quality. This product launch broadens the range of available contrast agents, offering better imaging solutions and reinforcing the importance of contrast media in various medical diagnostics.
Contrast Media/Contrast Agent Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Increasing Healthcare Expenditure
Rising healthcare expenditure, particularly in developing countries is facilitating the adoption of advanced diagnostic technologies and contrast agents._x000D_
Product Approvals and Launches
One of the major market trends includes the frequent product approvals and the launch of new and innovative contrast agents by key market players contributing to market growth by offering improved imaging solutions._x000D_
Awareness and Emphasis on Early Diagnosis
Increasing awareness about the importance of early diagnosis and preventive healthcare promotes the use of diagnostic imaging and, consequently, contrast media._x000D_
Collaborations and Partnerships
Strategic collaborations and partnerships among pharmaceutical companies, research organizations, and diagnostic imaging centers enhance the development and distribution of contrast media.
Contrast Media/Contrast Agent Market Segmentation
The EMR’s report titled “Contrast Media/Contrast Agent Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Segmentation Based on Product type is Anticipated to Witness Substantial Growth
By type, the market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media. Improved healthcare regulations, increased healthcare spending, and the influx of foreign investments are enhancing the accessibility and quality of medical care, leading to higher demand for contrast media/contrast agents. Government initiatives to improve healthcare infrastructure and increase access to diagnostic services in various regions further propel market growth.
Contrast Media/Contrast Agent Market Analysis by Region
Based on the region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the market share due to the rising burden of chronic diseases, the growing aging population, and the presence of advanced healthcare infrastructure. Further, the increasing technological advancements in contrast media/contrast agents, heightened awareness, and the surge in the adoption of these agents for better results are some of the factors supporting the market growth.
Europe also holds a high contrast media/contrast agent market value, driven by increasing investments in healthcare technologies and greater access to advanced medical devices. Additionally, Asia Pacific is expected to witness substantial market growth fueled by the growing patient pool and the increasing recognition of contrast media/contrast agent benefits. Increased government initiatives to improve healthcare services and rising disposable income are poised to boost the region’s market share.
Leading Players in the Contrast Media/Contrast Agent Market
The key features of the market report include patent analysis and strategic initiatives by the leading key players. The major companies in the market are as follows:
GE HealthCare
GE HealthCare is a global leader in medical technology, specializing in diagnostic imaging, patient monitoring, and life sciences. As a prominent player in the contrast media market, GE HealthCare offers products such as Omnipaque, Visipaque, Optison, and Clariscan, which enhance the quality and accuracy of X-ray, CT, MRI, and ultrasound imaging. The company's innovations focus on improving safety and efficacy in diagnostic procedures, solidifying its role in advancing healthcare delivery worldwide.
Bayer AG
Bayer AG is a leading global enterprise in the fields of healthcare and agriculture, headquartered in Leverkusen, Germany. In the contrast media market, Bayer offers products like Gadovist, Ultravist, and Eovist, which are used to enhance imaging in MRI, CT, and X-ray procedures. The company is known for its continuous innovation and commitment to improving diagnostic accuracy and patient safety, playing a crucial role in advancing medical imaging technologies globally.
Other key players in the market include Bracco Imaging S.P.A, Guerbet, Lantheus Holdings, Inc., Imax Diagnostics, TRIVITRON HEALTHCARE PRIVATE LIMITED, and Nano Therapeutics Pvt Ltd, among others.
Key Questions Answered in the Contrast Media/Contrast Agent Market Report
Contrast Media/Contrast Agent Market Overview
Contrast media, also known as contrast agents, are substances used in medical imaging to enhance the visibility of internal body structures and fluids during diagnostic procedures. These agents improve image contrast in various modalities such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Radiopaque contrast media, which include iodine-based and barium-sulfate compounds, are commonly used in X-ray and CT imaging to highlight blood vessels and gastrointestinal tracts. Paramagnetic agents, containing gadolinium, are used in MRI to enhance tissue differentiation. Microbubble contrast agents, used in ultrasound, improve the visualization of blood flow and organ structures. These agents are essential in modern diagnostic medicine, providing clearer and more detailed images for accurate diagnosis and treatment planning.
The shift towards minimally invasive diagnostic and therapeutic procedures has increased the utilization of contrast agents to enhance imaging accuracy and outcomes. Also, the growth in the number of diagnostic imaging centers, particularly in emerging economies, expands the accessibility and availability of imaging services, driving the demand for contrast agents.
Contrast Media/Contrast Agent Market Growth Drivers
Advancements in Imaging Technologies Augmenting the Market Growth
Advancements in imaging technologies improve the accuracy and quality of diagnostic procedures, driving the demand for contrast media. Enhanced imaging systems require high-quality contrast agents to optimize their performance. For instance, Siemens Healthineers introduced Naeotom Alpha, the world’s first photon-counting CT scanner with a technology that provides high-resolution images at lower radiation doses compared to traditional CT scanners. Photon-counting detectors capture more detailed information about tissues, improving contrast resolution and making the use of contrast media more effective. This advancement supports the growing need for precise imaging in complex medical conditions.
Frequent Product Approvals and Launches to Meet Rising Contrast Media/Contrast Agent Market Demand
The introduction of new and innovative contrast agents is expanding the options available to clinicians, enhancing the quality of diagnostic imaging and driving market growth. For example, in August 2022, Guerbet and Bracco Imaging received FDA approval for Gadopiclenol, a new macrocyclic gadolinium-based contrast agent (GBCA) for MRI. Gadopiclenol features high relaxivity, allowing for lower doses while still providing excellent image quality. This product launch broadens the range of available contrast agents, offering better imaging solutions and reinforcing the importance of contrast media in various medical diagnostics.
Contrast Media/Contrast Agent Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Increasing Healthcare Expenditure
Rising healthcare expenditure, particularly in developing countries is facilitating the adoption of advanced diagnostic technologies and contrast agents._x000D_
Product Approvals and Launches
One of the major market trends includes the frequent product approvals and the launch of new and innovative contrast agents by key market players contributing to market growth by offering improved imaging solutions._x000D_
Awareness and Emphasis on Early Diagnosis
Increasing awareness about the importance of early diagnosis and preventive healthcare promotes the use of diagnostic imaging and, consequently, contrast media._x000D_
Collaborations and Partnerships
Strategic collaborations and partnerships among pharmaceutical companies, research organizations, and diagnostic imaging centers enhance the development and distribution of contrast media.
Contrast Media/Contrast Agent Market Segmentation
The EMR’s report titled “Contrast Media/Contrast Agent Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Microbubble Contrast Media
- Barium-Based Contrast Media
- X-Ray/ Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Cardiovascular Disorders
- Cancer
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Nephrological Disorders
- Others
- Intravenous
- Oral Route
- Rectal Route
- Hospitals
- Diagnostic Imaging Centers
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on Product type is Anticipated to Witness Substantial Growth
By type, the market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media. Improved healthcare regulations, increased healthcare spending, and the influx of foreign investments are enhancing the accessibility and quality of medical care, leading to higher demand for contrast media/contrast agents. Government initiatives to improve healthcare infrastructure and increase access to diagnostic services in various regions further propel market growth.
Contrast Media/Contrast Agent Market Analysis by Region
Based on the region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the market share due to the rising burden of chronic diseases, the growing aging population, and the presence of advanced healthcare infrastructure. Further, the increasing technological advancements in contrast media/contrast agents, heightened awareness, and the surge in the adoption of these agents for better results are some of the factors supporting the market growth.
Europe also holds a high contrast media/contrast agent market value, driven by increasing investments in healthcare technologies and greater access to advanced medical devices. Additionally, Asia Pacific is expected to witness substantial market growth fueled by the growing patient pool and the increasing recognition of contrast media/contrast agent benefits. Increased government initiatives to improve healthcare services and rising disposable income are poised to boost the region’s market share.
Leading Players in the Contrast Media/Contrast Agent Market
The key features of the market report include patent analysis and strategic initiatives by the leading key players. The major companies in the market are as follows:
GE HealthCare
GE HealthCare is a global leader in medical technology, specializing in diagnostic imaging, patient monitoring, and life sciences. As a prominent player in the contrast media market, GE HealthCare offers products such as Omnipaque, Visipaque, Optison, and Clariscan, which enhance the quality and accuracy of X-ray, CT, MRI, and ultrasound imaging. The company's innovations focus on improving safety and efficacy in diagnostic procedures, solidifying its role in advancing healthcare delivery worldwide.
Bayer AG
Bayer AG is a leading global enterprise in the fields of healthcare and agriculture, headquartered in Leverkusen, Germany. In the contrast media market, Bayer offers products like Gadovist, Ultravist, and Eovist, which are used to enhance imaging in MRI, CT, and X-ray procedures. The company is known for its continuous innovation and commitment to improving diagnostic accuracy and patient safety, playing a crucial role in advancing medical imaging technologies globally.
Other key players in the market include Bracco Imaging S.P.A, Guerbet, Lantheus Holdings, Inc., Imax Diagnostics, TRIVITRON HEALTHCARE PRIVATE LIMITED, and Nano Therapeutics Pvt Ltd, among others.
Key Questions Answered in the Contrast Media/Contrast Agent Market Report
- What was the global contrast media/contrast agent market value in 2024?
- What is the global contrast media/contrast agent market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on application?
- What is the market breakup based on modality?
- What is the market segmentation by type?
- What is the market segmentation by route of administration?
- What is the market breakup by end users?
- What are the major factors aiding the global contrast media/contrast agent market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major market trends influencing the market?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the rise in the geriatric population impact the market size?
- How do the technological innovations in contrast media/contrast agent affect the market landscape?
- Which application area is expected to have a high market value in the coming years?
- Who are the key players involved in the contrast media/contrast agent market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Contrast Media/Contrast Agent Market Overview
- 3.1 Global Contrast Media/Contrast Agent Market Historical Value (2018-2024)
- 3.2 Global Contrast Media/Contrast Agent Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Contrast Media/Contrast Agent Market Landscape*
- 5.1 Global Contrast Media/Contrast Agent: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Contrast Media/Contrast Agent: Product Landscape
- 5.2.1 Analysis by Type
- 6 Global Contrast Media/Contrast Agent Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Environmental
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Ethical
- 6.3.6 Legal
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Contrast Media/Contrast Agent Market Segmentation (218-2034)
- 7.1 Global Contrast Media/Contrast Agent Market (2018-2034) by Type
- 7.1.1 Market Overview
- 7.1.2 Iodinated Contrast Media
- 7.1.3 Gadolinium-Based Contrast Media
- 7.1.4 Microbubble Contrast Media
- 7.1.5 Barium-Based Contrast Media
- 7.2 Global Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 7.2.1 Market Overview
- 7.2.2 X-Ray/ Computed Tomography (CT)
- 7.2.3 Magnetic Resonance Imaging (MRI)
- 7.2.4 Ultrasound
- 7.3 Global Contrast Media/Contrast Agent Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Cardiovascular Disorders
- 7.3.3 Cancer
- 7.3.4 Gastrointestinal Disorders
- 7.3.5 Musculoskeletal Disorders
- 7.3.6 Neurological Disorders
- 7.3.7 Nephrological Disorders
- 7.3.8 Others
- 7.4 Global Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 7.4.1 Market Overview
- 7.4.2 Intravenous
- 7.4.3 Oral Route
- 7.4.4 Rectal Route
- 7.5 Global Contrast Media/Contrast Agent Market (2018-2034) by End User
- 7.5.1 Market Overview
- 7.5.2 Hospitals
- 7.5.3 Diagnostic Imaging Centers
- 7.5.4 Others
- 7.6 Global Contrast Media/Contrast Agent Market (2018-2034) by Region
- 7.6.1 Market Overview
- 7.6.2 North America
- 7.6.3 Europe
- 7.6.4 Asia Pacific
- 7.6.5 Latin America
- 7.6.6 Middle East and Africa
- 8 North America Contrast Media/Contrast Agent Market (218-2034)
- 8.1 North America Contrast Media/Contrast Agent Market (2018-2034) by Type
- 8.1.1 Market Overview
- 8.1.2 Iodinated Contrast Media
- 8.1.3 Gadolinium-Based Contrast Media
- 8.1.4 Microbubble Contrast Media
- 8.1.5 Barium-Based Contrast Media
- 8.2 North America Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 8.2.1 Market Overview
- 8.2.2 X-Ray/ Computed Tomography (CT)
- 8.2.3 Magnetic Resonance Imaging (MRI)
- 8.2.4 Ultrasound
- 8.3 North America Contrast Media/Contrast Agent Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Cardiovascular Disorders
- 8.3.3 Cancer
- 8.3.4 Gastrointestinal Disorders
- 8.3.5 Musculoskeletal Disorders
- 8.3.6 Neurological Disorders
- 8.3.7 Nephrological Disorders
- 8.3.8 Others
- 8.4 North America Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 8.4.1 Market Overview
- 8.4.2 Intravenous
- 8.4.3 Oral Route
- 8.4.4 Rectal Route
- 8.5 North America Contrast Media/Contrast Agent Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.2 Canada
- 9 Europe Contrast Media/Contrast Agent Market (218-2034)
- 9.1 Europe Contrast Media/Contrast Agent Market (2018-2034) by Type
- 9.1.1 Market Overview
- 9.1.2 Iodinated Contrast Media
- 9.1.3 Gadolinium-Based Contrast Media
- 9.1.4 Microbubble Contrast Media
- 9.1.5 Barium-Based Contrast Media
- 9.2 Europe Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 9.2.1 Market Overview
- 9.2.2 X-Ray/ Computed Tomography (CT)
- 9.2.3 Magnetic Resonance Imaging (MRI)
- 9.2.4 Ultrasound
- 9.3 Europe Contrast Media/Contrast Agent Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Cardiovascular Disorders
- 9.3.3 Cancer
- 9.3.4 Gastrointestinal Disorders
- 9.3.5 Musculoskeletal Disorders
- 9.3.6 Neurological Disorders
- 9.3.7 Nephrological Disorders
- 9.3.8 Others
- 9.4 Europe Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 9.4.1 Market Overview
- 9.4.2 Intravenous
- 9.4.3 Oral Route
- 9.4.4 Rectal Route
- 9.5 Europe Contrast Media/Contrast Agent Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.2 Germany
- 9.5.3 France
- 9.5.4 Italy
- 9.5.5 Others
- 10 Asia Pacific Contrast Media/Contrast Agent Market (218-2034)
- 10.1 Asia Pacific Contrast Media/Contrast Agent Market (2018-2034) by Type
- 10.1.1 Market Overview
- 10.1.2 Iodinated Contrast Media
- 10.1.3 Gadolinium-Based Contrast Media
- 10.1.4 Microbubble Contrast Media
- 10.1.5 Barium-Based Contrast Media
- 10.2 Asia Pacific Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 10.2.1 Market Overview
- 10.2.2 X-Ray/ Computed Tomography (CT)
- 10.2.3 Magnetic Resonance Imaging (MRI)
- 10.2.4 Ultrasound
- 10.3 Asia Pacific Contrast Media/Contrast Agent Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Cardiovascular Disorders
- 10.3.3 Cancer
- 10.3.4 Gastrointestinal Disorders
- 10.3.5 Musculoskeletal Disorders
- 10.3.6 Neurological Disorders
- 10.3.7 Nephrological Disorders
- 10.3.8 Others
- 10.4 Asia Pacific Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 10.4.1 Market Overview
- 10.4.2 Intravenous
- 10.4.3 Oral Route
- 10.4.4 Rectal Route
- 10.5 Asia Pacific Contrast Media/Contrast Agent Market (2018-2034) by Country
- 10.5.1 China
- 10.5.2 Japan
- 10.5.3 India
- 10.5.4 ASEAN
- 10.5.5 Australia
- 10.5.6 Others
- 11 Latin America Contrast Media/Contrast Agent Market (218-2034
- 11.1 Latin America Contrast Media/Contrast Agent Market (2018-2034) by Type
- 11.1.1 Market Overview
- 11.1.2 Iodinated Contrast Media
- 11.1.3 Gadolinium-Based Contrast Media
- 11.1.4 Microbubble Contrast Media
- 11.1.5 Barium-Based Contrast Media
- 11.2 Latin America Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 11.2.1 Market Overview
- 11.2.2 X-Ray/ Computed Tomography (CT)
- 11.2.3 Magnetic Resonance Imaging (MRI)
- 11.2.4 Ultrasound
- 11.3 Latin America Contrast Media/Contrast Agent Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Cardiovascular Disorders
- 11.3.3 Cancer
- 11.3.4 Gastrointestinal Disorders
- 11.3.5 Musculoskeletal Disorders
- 11.3.6 Neurological Disorders
- 11.3.7 Nephrological Disorders
- 11.3.8 Others
- 11.4 Latin America Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 11.4.1 Market Overview
- 11.4.2 Intravenous
- 11.4.3 Oral Route
- 11.4.4 Rectal Route
- 11.5 Latin America Contrast Media/Contrast Agent Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Mexico
- 11.5.4 Others
- 12 Middle East and Africa Contrast Media/Contrast Agent Market (218-2034)
- 12.1 Middle East and Africa Contrast Media/Contrast Agent Market (2018-2034) by Type
- 12.1.1 Market Overview
- 12.1.2 Iodinated Contrast Media
- 12.1.3 Gadolinium-Based Contrast Media
- 12.1.4 Microbubble Contrast Media
- 12.1.5 Barium-Based Contrast Media
- 12.2 Middle East and Africa Contrast Media/Contrast Agent Market (2018-2034) by Modality
- 12.2.1 Market Overview
- 12.2.2 X-Ray/ Computed Tomography (CT)
- 12.2.3 Magnetic Resonance Imaging (MRI)
- 12.2.4 Ultrasound
- 12.3 Middle East and Africa Contrast Media/Contrast Agent Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Cardiovascular Disorders
- 12.3.3 Cancer
- 12.3.4 Gastrointestinal Disorders
- 12.3.5 Musculoskeletal Disorders
- 12.3.6 Neurological Disorders
- 12.3.7 Nephrological Disorders
- 12.3.8 Others
- 12.4 Middle East and Africa Contrast Media/Contrast Agent Market (2018-2034) by Route of Administration
- 12.4.1 Market Overview
- 12.4.2 Intravenous
- 12.4.3 Oral Route
- 12.4.4 Rectal Route
- 12.5 Middle East and Africa Contrast Media/Contrast Agent Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.2 United Arab Emirates
- 12.5.3 Nigeria
- 12.5.4 South Africa
- 12.5.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 INDIA CDSCO
- 13.5 JAPAN PMDA
- 13.6 Others
- 14 Patent Analysis
- 14.1 Analysis by Type of Patent
- 14.2 Analysis by Publication Year
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Patent Age
- 14.5 Analysis by CPC Analysis
- 14.6 Analysis by Patent Valuation
- 14.7 Analysis by Key Players
- 15 Strategic Initiatives
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership and Collaborations
- 15.3 Analysis by Joint Ventures
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Market Share Analysis, By Region (Top 5 Companies)
- 16.1.1 Market Share Analysis: Global
- 16.1.2 Market Share Analysis: North America
- 16.1.3 Market Share Analysis: Europe
- 16.1.4 Market Share Analysis: Asia-Pacific
- 16.1.5 Market Share Analysis: Others
- 16.2 GE HealthCare
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 Bracco Imaging S.P.A
- 16.3.1 Product Portfolio
- 16.3.2 Demographic Reach and Achievements
- 16.3.3 Mergers and Acquisitions
- 16.3.4 Certifications
- 16.4 Bayer AG
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Guerbet
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Lantheus Holdings, Inc.
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Imax diagnostics
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 TRIVITRON HEALTHCARE PRIVATE LIMITED
- 16.8.1 Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 Nano Therapeutics Pvt Ltd
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 17 Global Contrast Media/Contrast Agent Market – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
